SCHEMBL10195254

SCHEMBL10195254

CCc1ccc(Oc2ncccn2)cc1C1=C(O)C(C)(C)OC(C)(C)C1=O

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 3/20 0.40
ALDH1A1 P00352 3/20 0.40
GAA P10253 3/20 0.40
HSD17B10 Q99714 2/20 0.40
HPGD P15428 1/20 0.40
SMN1; SMN2 Q16637 3/20 0.37
MEN1 O00255 2/20 0.36
KMT2A Q03164 2/20 0.36
RAB9A P51151 3/20 0.35
MAPT P10636 3/20 0.33
NPC1 O15118 2/20 0.33
ALK Q9UM73 1/20 0.32
ALOX5AP P20292 1/20 0.32
FEN1 P39748 1/20 0.32
L3MBTL1 Q9Y468 1/20 0.32
LMNA P02545 3/20 0.32
HTT P42858 2/20 0.31
RAF1 P04049 1/20 0.31
MAP2K1 Q02750 1/20 0.31
PTGS2 P35354 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10195232 0.89 KDM4E (0.31) KDM4EALDH1A1GAAHSD17B10HPGD
SCHEMBL10195160 0.89 PTGS2 (0.40) L3MBTL1PTGS2
SCHEMBL10195211 0.89 KDM4E (0.30) KDM4EALDH1A1GAAHSD17B10HPGD
SCHEMBL10195213 0.89 FFAR1 (0.34) KDM4EALDH1A1GAAHSD17B10HPGD
SCHEMBL13286406 0.88 ALOX5AP (0.39) KDM4EALDH1A1GAAHSD17B10HPGD
SCHEMBL10195250 0.87 P2RX3 (0.34) KDM4EALDH1A1GAAHSD17B10HPGD
SCHEMBL10195242 0.87 GAA (0.35) KDM4EALDH1A1GAAHSD17B10HPGD
SCHEMBL10195214 0.86 ALK (0.30) KDM4EALDH1A1GAAHSD17B10HPGD
SCHEMBL10195212 0.85 BTK (0.31) ALOX5APFEN1RAF1MAP2K1
SCHEMBL10195166 0.84 MAPT (0.34) KDM4ESMN1; SMN2MEN1KMT2AMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2387569-B1 HERBCIDES SYNGENTA LTD (GB) 2016-06-15 EP disclosed
US-20140378305-A1 NOVEL HERBICIDES SYNGENTA LIMITED (GB) 2014-12-25 US disclosed
US-20140378305-A1 NOVEL HERBICIDES SYNGENTA LIMITED (GB) 2014-12-25 US disclosed
US-8865623-B2 Herbicidally active cyclic diones and derivatives thereof, processes for their preparation, compositions, and method of controlling weeds SYNGENTA LIMITED (GB) 2014-10-21 US disclosed
US-8865623-B2 Herbicidally active cyclic diones and derivatives thereof, processes for their preparation, compositions, and method of controlling weeds SYNGENTA LIMITED (GB) 2014-10-21 US disclosed
US-20120021907-A1 NOVEL HERBICIDES SYNGENTA CROP PROTECTION LLC (US) 2012-01-26 US disclosed
US-20120021907-A1 NOVEL HERBICIDES SYNGENTA CROP PROTECTION LLC (US) 2012-01-26 US disclosed
WO-2010081755-A1 NOVEL HERBICIDES SYNGENTA LIMITED (GB) 2010-07-22 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20140378305-A1 NOVEL HERBICIDES DDT, CYP4X1, CYP1B1 KDM4E 712/4885ALDH1A1 45/4885GAA 247/4885
US-20120021907-A1 NOVEL HERBICIDES DDT, CYP4X1, CYP1B1 KDM4E 1092/4885ALDH1A1 14/4885GAA 478/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.